BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
31 results:

  • 1. Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma.
    Mo Z; Liu J; Zhang J; Deng Y; Xu M; Jiang Y
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110973. PubMed ID: 37769536
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Artificial Intelligence-Assisted Classification of Gliomas Using Whole Slide Images.
    Jose L; Liu S; Russo C; Cong C; Song Y; Rodriguez M; Di Ieva A
    Arch Pathol Lab Med; 2023 Aug; 147(8):916-924. PubMed ID: 36445697
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Applications of the Grading Scales for the Detection of Ototoxicity in Children after treatment of Neuroblastoma and Extracranial germinal tumor.
    Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D
    Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pathological prognosis classification of patients with neuroblastoma using computational pathology analysis.
    Liu Y; Jia Y; Hou C; Li N; Zhang N; Yan X; Yang L; Guo Y; Chen H; Li J; Hao Y; Liu J
    Comput Biol Med; 2022 Oct; 149():105980. PubMed ID: 36001926
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost-Effectiveness of Pembrolizumab Versus Carboplatin and Paclitaxel in Patients With Unresectable or Metastatic Melanoma After First-Line treatment in China.
    Tang WX; Shao RJ; Wang J; Scherrer E; Ma AX; Aguiar-Ibáñez R
    Value Health Reg Issues; 2022; 27():99-107. PubMed ID: 34922053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk Factors for Development of Rectal Neuroendocrine tumors Longer Than 9 mm: Retrospective Cohort.
    de Castro JSL; da Rocha ECV; do Vale VA; Mendonça P; Marques OW; Taglieri E; Koyama FSC; Cardoso Filho CAM; Nakagawa WT
    Turk J Gastroenterol; 2021 Aug; 32(8):616-621. PubMed ID: 34528874
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dual-layer detector spectral CT-a new supplementary method for preoperative evaluation of glioma.
    Yingying L; Zhe Z; Xiaochen W; Xiaomei L; Nan J; Shengjun S
    Eur J Radiol; 2021 May; 138():109649. PubMed ID: 33730659
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model.
    Xia W; Hu B; Li H; Shi W; Tang Y; Yu Y; Geng C; Wu Q; Yang L; Yu Z; Geng D; Li Y
    J Magn Reson Imaging; 2021 Sep; 54(3):880-887. PubMed ID: 33694250
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2.
    Papantoniou D; Grönberg M; Landerholm K; Welin S; Ziolkowska B; Nordvall D; Janson ET
    Endocrine; 2021 Jun; 72(3):893-904. PubMed ID: 33244704
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
    Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
    PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
    Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
    Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
    Schell M; Pflüger I; Brugnara G; Isensee F; Neuberger U; Foltyn M; Kessler T; Sahm F; Wick A; Nowosielski M; Heiland S; Weller M; Platten M; Maier-Hein KH; Von Deimling A; Van Den Bent MJ; Gorlia T; Wick W; Bendszus M; Kickingereder P
    Neuro Oncol; 2020 Nov; 22(11):1667-1676. PubMed ID: 32393964
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
    Bowden GN; Kim JO; Faramand A; Fallon K; Flickinger J; Lunsford LD
    J Neurosurg; 2020 May; 134(5):1430-1434. PubMed ID: 32384280
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Abdominal Fat Graft for Sellar Reconstruction: Retrospective Outcomes Review and Technical Note.
    Roca E; Penn DL; Safain MG; Burke WT; Castlen JP; Laws ER
    Oper Neurosurg (Hagerstown); 2019 Jun; 16(6):667-674. PubMed ID: 30124966
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series.
    Takahashi H; Kahramangil B; Berber E
    Surgery; 2018 Apr; 163(4):709-713. PubMed ID: 29273176
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effectiveness, toxicity, and economic evaluation of ipilimumab for the treatment of patients with metastatic melanoma in the Spanish outpatient setting.
    Guglieri-López B; Pérez-Pitarch A; Porta Oltra B; Ferriols-Lisart F; Royo-Peiró Á; Climente-Martí M
    Anticancer Drugs; 2016 Aug; 27(7):679-84. PubMed ID: 27058705
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
    Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
    Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.
    Schlamann A; von Bueren AO; Hagel C; Zwiener I; Seidel C; Kortmann RD; Müller K
    PLoS One; 2014; 9(7):e101211. PubMed ID: 24991807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.